SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Momentum Trade Ideas: SEBI RAs See Breakout Opportunities In These Pharma And Industrial Stocks

Equity

Analysts have highlighted Jagsonpal, Alkem, Senores Pharma, and Cummins India as strong near-term opportunities based on technical setups and volume action.

Senores Pharmaceuticals Ltd. engages in the manufacture and sale of pharmaceutical and generic medicines. It operates through the following segments: Regulated Markets Business, Emerging Markets Business, Critical Care Injectables Business, API Business. The Regulated Markets Business segment involves in the contract development and manufacturing operations and contract manufacturing operations. The Emerging Markets Business segment provides the development, manufacturing and sale of pharmaceutical products. The Critical Care Injectables Business segment engages in the distribution of critical care injectables to hospitals. The API Business segment manufactures APIs for the domestic market and SAARC countries. The company was founded on December 26, 2017 and is headquartered in Ahmedabad, India.

Senores Pharmaceuticals Ltd.

Neutral Sentiment

Two SEBI-registered analysts have highlighted four stocks that show promising technical setups and volume action.While Financial Sarthis is bullish on Jagsonpal Pharmaceuticals and Alkem Laboratories, analyst Kavita Agrawal has picked Senores Pharma and Cummins India as ideal opportunities.&nbsp;Let’s take a closer look at why these stocks are worth adding to your watchlist.Analyst&nbsp;<a href="https://stocktwits.com/financialsarthis">Financial Sarthis</a> has flagged two pharma stocks to add to the stock watchlist.Jagsonpal Pharmaceuticals<a href="https://stocktwits.com/symbol/JAGSNPHARM.NSE">Jagson Pharma</a> recently pulled off a horizontal breakout above ₹279.45. The massive volume spike indicates that smart money is entering the stock. They have identified the next target at ₹325 and higher.&nbsp;Alkem Laboratories<a href="https://stocktwits.com/symbol/ALKEM.NSE">Alkem</a> has formed a base consolidation. Watch for a breakout above ₹5,075, with support at ₹4,930. Volumes have seen a gradual build-up, but no explosive volume yet.&nbsp;He added that the stock is testing a key horizontal resistance at ₹5,050. A breakout above this zone, supported by volume, could open up a rally toward ₹5,250–5,400.<stembedurl>https://stocktwits.com/financialsarthis/message/622673870</stembedurl>Meanwhile, analyst&nbsp;<a href="https://stocktwits.com/KavitaAgrawalCMTCFA">Kavita Agrawal</a> has identified Senores Pharma and Cummins for significant upside potential ahead.Senores PharmaceuticalOn its daily chart, Agrawal observed a strong breakout on high volumes supported by a healthy pullback and low volumes, which is considered a bullish sign.&nbsp;&nbsp;She added that the current setup in&nbsp;<a href="https://stocktwits.com/symbol/SENORES.NSE">Senores</a> looks attractive with the trendline support holding well. According to her, this pullback presents a great entry opportunity with an immediate target of ₹834, accompanied by a stop-loss below ₹600.<stembedurl>https://stocktwits.com/KavitaAgrawalCMTCFA/message/622700109</stembedurl>Cummins IndiaHer other recommendation is&nbsp;<a href="https://stocktwits.com/symbol/CUMMINSIND.NSE">Cummins India</a>. Momentum is strong across the board, and volume picked up during the upward move.&nbsp;She added that the stock has now reached that recharge zone, making this a buy-on-dip opportunity. Agrawal identified an ideal entry around ₹3,450, with a suggested stop loss at ₹3,325 for a potential target of ₹3,891.<stembedurl>https://stocktwits.com/KavitaAgrawalCMTCFA/message/622700291</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Analysts have highlighted Jagsonpal, Alkem, Senores Pharma, and Cummins India as strong near-term opportunities based on technical setups and volume action

Current Price	1,210.20
Prev Close	1,215.20
Open	1,208.00
Dividend Yield	0.00%
50-Day Moving Average	1,317.96
Beta	-0.19
Avg. Volume	334,574.77
PE Ratio	41.99

52-Week High	1,599.00
52-Week Low	706.00
Market Capitalization	53.97B
EPS (Annual)	25.05
Price to Book	5.59
Revenue Per Employee	17.19M

Feed

News

Sentiment

Fundamentals

Info

SENORES.NSE Fundamentals